AHPRA (2025) Joint statement on professional responsibilities for prescribing and dispensing medicines. Melbourne, VIC, Australia: Australian Health Practitioner Regulation Agency
2.
Australian Government (2025) SAS-B Approvals Portal.
3.
CarahNBrodmerkelS (2021) Alcohol marketing in the era of digital media platforms. Journal of Studies on Alcohol and Drugs82: 18–27.
4.
ChopraP (2017) ‘Medical’ marijuana is incompatible with mental health promotion. Australian & New Zealand Journal of Psychiatry51: 1060–1061.
5.
DawsonDChanGStjepanovicD, et al. (2025) The prevalence and correlates of self-reported cannabis use for medicinal, dual and recreational motives in Australia: Findings from the National Drug Strategy Household Survey 2022/23. Drug and Alcohol Review44: 1351–1364.
6.
DawsonDStjepanovicDLorenzettiV, et al (2024) The prevalence of cannabis use disorders in people who use medicinal cannabis: A systematic review and meta-analysis. Drug and Alcohol Dependence257: 111263.
LimCCLawrieEWilsonH, et al. (2025) Research letter: Unveiling the boundaries: Analysing advertising breaches in the promotion of medicinal cannabis in Australia. Australian & New Zealand Journal of Psychiatry59: 183–186.
9.
LupkeKGerardAMurdochB, et al. (2023) Impacts of medicinal cannabis on an early psychosis service. Australas Psychiatry32: 164.
